This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
health care | 279 |
swine fever | 221 |
african swine | 214 |
african americans | 209 |
public health | 208 |
african american | 204 |
fever virus | 156 |
west african | 151 |
ebola virus | 148 |
african countries | 126 |
human rights | 93 |
mental health | 89 |
virus disease | 87 |
mouth disease | 80 |
vaccinia virus | 79 |
united states | 73 |
risk factors | 73 |
hiv aids | 72 |
disease virus | 70 |
african wild | 69 |
west africa | 59 |
amino acid | 58 |
herpes simplex | 57 |
virus replication | 57 |
infected cells | 56 |
wild dogs | 56 |
infectious diseases | 55 |
crc screening | 55 |
simplex virus | 55 |
world health | 55 |
traditional medicines | 53 |
sierra leone | 52 |
colorectal cancer | 52 |
coronavirus disease | 52 |
health services | 51 |
bagv isolates | 50 |
social distancing | 49 |
genetic diversity | 48 |
cord uid | 48 |
falciparum malaria | 48 |
doc id | 48 |
spotted hyenas | 47 |
lycaon pictus | 47 |
health organization | 47 |
respiratory syndrome | 46 |
cancer screening | 46 |
acute respiratory | 45 |
ebola epidemic | 45 |
positive selection | 44 |
american men | 44 |
health disparities | 43 |
african traditional | 43 |
african ebola | 42 |
among african | 42 |
severe acute | 42 |
novel coronavirus | 42 |
severe malaria | 41 |
south africa | 40 |
viral dna | 40 |
black men | 39 |
infectious disease | 39 |
american women | 39 |
red zone | 39 |
stool blood | 39 |
new york | 39 |
systematic review | 39 |
dna replication | 38 |
replication complex | 37 |
poster sessions | 37 |
intensive care | 36 |
recombination events | 36 |
saharan africa | 36 |
asfv genomes | 36 |
natural selection | 35 |
virus infection | 35 |
sapovirus infection | 35 |
american patients | 35 |
disease control | 34 |
south kivu | 34 |
viral rna | 34 |
viral replication | 33 |
clinical trials | 33 |
data collection | 33 |
colored fruit | 33 |
canine distemper | 33 |
insulin resistance | 33 |
fruit bat | 33 |
african straw | 33 |
care system | 32 |
health status | 32 |
socioeconomic status | 32 |
african bagv | 32 |
health promotion | 31 |
primary care | 30 |
pandemic influenza | 30 |
healthcare workers | 30 |
community health | 30 |
virus type | 29 |
neck region | 29 |
urban health | 29 |
virus factories | 29 |
ssa countries | 29 |
drug use | 28 |
urban areas | 28 |
health systems | 28 |
viral proteins | 28 |
recombinant virus | 28 |
health centre | 27 |
healthcare system | 27 |
copies per | 27 |
drug users | 27 |
may also | 27 |
health problems | 27 |
cells infected | 27 |
health needs | 27 |
endoplasmic reticulum | 27 |
solid waste | 26 |
ww treatment | 26 |
kidney disease | 26 |
syndrome coronavirus | 26 |
health outcomes | 26 |
street youth | 26 |
repeated elements | 26 |
african continent | 26 |
developing countries | 26 |
important role | 26 |
illness severity | 25 |
african trypanosomiasis | 25 |
structural proteins | 25 |
domestic pigs | 25 |
plasmodium falciparum | 25 |
kivu province | 25 |
inner city | 25 |
diabetes mellitus | 25 |
cerebral malaria | 25 |
health system | 25 |
african populations | 24 |
energy consumption | 24 |
ebov gp | 24 |
informed consent | 24 |
necrosis factor | 24 |
years ago | 24 |
art para | 24 |
black women | 24 |
physical activity | 24 |
increased risk | 24 |
phylogenetic analysis | 23 |
ebola outbreak | 23 |
high risk | 23 |
virus assembly | 23 |
rna polymerase | 23 |
replication complexes | 23 |
case study | 23 |
social justice | 23 |
substance use | 23 |
higher risk | 23 |
traditional healers | 23 |
vero cells | 23 |
assembly sites | 23 |
life cycle | 23 |
bat cells | 23 |
energy return | 23 |
systemic racism | 22 |
palm civet | 22 |
capsid protein | 22 |
replication sites | 22 |
waste management | 22 |
health interventions | 22 |
immune system | 22 |
human african | 22 |
inflammatory cytokines | 22 |
white patients | 22 |
infectious sw | 22 |
asfv strains | 22 |
immune responses | 22 |
pregnant women | 22 |
blood testing | 22 |
social determinants | 21 |
service providers | 21 |
homologous recombination | 21 |
ethnic groups | 21 |
logistic regression | 21 |
human genome | 21 |
american communities | 21 |
high levels | 20 |
venous thromboembolism | 20 |
membrane protein | 20 |
less likely | 20 |
care services | 20 |
rural areas | 20 |
york city | 20 |
masked palm | 20 |
host range | 20 |
wide range | 20 |
stranded rna | 20 |
presentation will | 20 |
rna viruses | 20 |
mortality rates | 20 |
heart failure | 20 |
cardiovascular disease | 20 |
sleeping sickness | 20 |
mj kg | 20 |
bagv genome | 20 |
urban poor | 20 |
care workers | 20 |
risk factor | 20 |
previously described | 20 |
contact tracing | 19 |
case definition | 19 |
african governments | 19 |
bagv sequences | 19 |
wild carnivores | 19 |
nucleic acid | 19 |
hospitalized patients | 19 |
social support | 19 |
african charter | 19 |
social capital | 19 |
spotted hyena | 19 |
low income | 19 |
clinical features | 18 |
future outbreaks | 18 |
social services | 18 |
infected cell | 18 |
obesity among | 18 |
performed using | 18 |
community members | 18 |
control measures | 18 |
tumor necrosis | 18 |
rna replication | 18 |
african children | 18 |
general population | 18 |
african palm | 18 |
replicase proteins | 18 |
dengue virus | 18 |
time pcr | 18 |
harm reduction | 18 |
severe covid | 18 |
wilcoxon rank | 17 |
animal health | 17 |
rank sum | 17 |
sum test | 17 |
focus groups | 17 |
years old | 17 |
balancing selection | 17 |
codon usage | 17 |
binding protein | 17 |
genome sequences | 17 |
case fatality | 17 |
higher rates | 17 |
health insurance | 17 |
asfv infection | 17 |
family income | 17 |
american community | 17 |
cell lines | 17 |
many african | 17 |
primary health | 17 |
fruit bats | 17 |
results suggest | 17 |
african isolates | 17 |
immune response | 17 |
health policy | 17 |
influenza pandemic | 17 |
african region | 17 |
present study | 17 |
host cell | 17 |
gene expression | 17 |
hemorrhagic fever | 16 |
structural protein | 16 |
electron microscopy | 16 |
saharan african | 16 |
cai values | 16 |
sequence alignment | 16 |
virus particles | 16 |
health research | 16 |
structural rna | 16 |
san francisco | 16 |
protective equipment | 16 |
health conditions | 16 |
innate immunity | 16 |
dna polymerase | 16 |
confirmed cases | 16 |
service delivery | 16 |
urban settings | 16 |
viral particles | 16 |
one study | 16 |
cohort study | 16 |
wild dog | 16 |
minority communities | 16 |
air pollution | 16 |
clinical trial | 16 |
highly conserved | 16 |
ethnic minority | 16 |
bagaza virus | 16 |
capsid proteins | 16 |
included studies | 16 |
monoclonal antibody | 16 |
los angeles | 16 |
significantly associated | 16 |
ethical issues | 16 |
recombination event | 16 |
selective pressures | 16 |
human populations | 16 |
study population | 16 |
rna domains | 16 |
democratic republic | 16 |
genetic variants | 16 |
among patients | 15 |
disease outbreak | 15 |
captive african | 15 |
modern humans | 15 |
severe disease | 15 |
sample size | 15 |
mortality rate | 15 |
secretory pathway | 15 |
type inclusions | 15 |
will provide | 15 |
disease severity | 15 |
factors associated | 15 |
icu admission | 15 |
disease burden | 15 |
cultural differences | 15 |
rabies virus | 15 |
golgi apparatus | 15 |
converting enzyme | 15 |
international law | 15 |
health service | 15 |
virus factory | 15 |
side effects | 15 |
selective pressure | 15 |
red blood | 15 |
west nile | 15 |
burial rites | 15 |
lessons learned | 15 |
blood pressure | 15 |
clinical signs | 15 |
isothermal amplification | 15 |
sequence data | 15 |
infection prevalence | 15 |
previous studies | 14 |
sapovirus strains | 14 |
least one | 14 |
per microliter | 14 |
care providers | 14 |
polymerase chain | 14 |
ethical considerations | 14 |
africa cdc | 14 |
dense bodies | 14 |
diverse populations | 14 |
best interest | 14 |
avian influenza | 14 |
viral factory | 14 |
family members | 14 |
malarial disease | 14 |
asfv detection | 14 |
research project | 14 |
developed countries | 14 |
racial disparities | 14 |
viral factories | 14 |
medical care | 14 |
angiotensin ii | 14 |
homeless people | 14 |
cervical cancer | 14 |
mitochondrial dysfunction | 14 |
face masks | 14 |
public policy | 14 |
chain reaction | 14 |
coding sequence | 14 |
evd epidemic | 14 |
sickle cell | 14 |
recent study | 14 |
large number | 14 |
vaccine development | 14 |
south african | 14 |
fatality rate | 13 |
sars coronavirus | 13 |
heart disease | 13 |
closely related | 13 |
ethnic disparities | 13 |
constitutional court | 13 |
viral genome | 13 |
african population | 13 |
full development | 13 |
made available | 13 |
data collected | 13 |
injection drug | 13 |
african outbreak | 13 |
asian msm | 13 |
recombinase polymerase | 13 |
genetic variation | 13 |
older age | 13 |
lateral flow | 13 |
american families | 13 |
food insecurity | 13 |
sectional study | 13 |
middle east | 13 |
polyprotein sequences | 13 |
evd survivors | 13 |
previously reported | 13 |
east africa | 13 |
viral infections | 13 |
clinical characteristics | 13 |
phylogenetic trees | 13 |
cell line | 13 |
gene encoding | 13 |
based research | 13 |
urban communities | 13 |
full text | 13 |
traditional medicine | 13 |
eastern mediterranean | 13 |
recombination region | 13 |
major capsid | 13 |
health professionals | 13 |
hospital admission | 13 |
high prevalence | 13 |
distemper virus | 13 |
symptom onset | 13 |
mosaic virus | 13 |
metabolic acidosis | 13 |
polymerase amplification | 13 |
care unit | 13 |
coding regions | 13 |
blood samples | 13 |
open reading | 13 |
ethical challenges | 13 |
southern states | 13 |
sequence variation | 13 |
sugar cane | 13 |
ns proteins | 13 |
health workers | 13 |
infectious agents | 12 |
drug treatment | 12 |
fusion protein | 12 |
per reaction | 12 |
black americans | 12 |
global health | 12 |
population health | 12 |
bone marrow | 12 |
virus dna | 12 |
replication compartments | 12 |
nuclear inclusions | 12 |
two genes | 12 |
factory formation | 12 |
level sep | 12 |
pfu cell | 12 |
conserved structural | 12 |
significantly higher | 12 |
cd cd | 12 |
intergenic region | 12 |
trypanosoma brucei | 12 |
type diabetes | 12 |
substance abuse | 12 |
medical services | 12 |
rdrp gene | 12 |
lesson learned | 12 |
disease outbreaks | 12 |
regional meetings | 12 |
virus particle | 12 |
racial ethnic | 12 |
united nations | 12 |
ebola treatment | 12 |
codon adaptation | 12 |
preventive measures | 12 |
capacity building | 12 |
study design | 12 |
task force | 12 |
ul gene | 12 |
breast cancer | 12 |
disease prevention | 12 |
emergency response | 12 |
personal protective | 12 |
clinical management | 12 |
two different | 12 |
health issues | 12 |
local health | 12 |
pilot study | 12 |
african lion | 12 |
gene product | 12 |
plasma membrane | 12 |
young people | 11 |
health information | 11 |
molecular epidemiology | 11 |
scientific research | 11 |
transmission dynamics | 11 |
traditional healer | 11 |
high school | 11 |
serengeti ecosystem | 11 |
community capacity | 11 |
long term | 11 |
treatment alternatives | 11 |
er membranes | 11 |
people living | 11 |
adaptive immune | 11 |
aged years | 11 |
latin american | 11 |
study showed | 11 |
human immune | 11 |
palm civets | 11 |
monoclonal antibodies | 11 |
scientific evidence | 11 |
body mass | 11 |
male sex | 11 |
viral protein | 11 |
human cytomegalovirus | 11 |
dna synthesis | 11 |
health organizations | 11 |
activity report | 11 |
unwanted sexual | 11 |
clan size | 11 |
medical staff | 11 |
eidolon helvum | 11 |
target population | 11 |
autoimmune diseases | 11 |
younger children | 11 |
ebov infection | 11 |
live cells | 11 |
local community | 11 |
regression models | 11 |
member states | 11 |
among women | 11 |
frog virus | 11 |
jury agreement | 11 |
cell receptor | 11 |
randomized controlled | 11 |
median cai | 11 |
statistically significant | 11 |
study reported | 11 |
health measures | 11 |
adjusted models | 11 |
minority groups | 11 |
sapovirus rna | 11 |
decision making | 11 |
household income | 11 |
multiple sequence | 11 |
sequence analysis | 11 |
infectious waste | 11 |
membrane rearrangements | 11 |
mass index | 11 |
nucleotide substitution | 11 |
dendritic cell | 11 |
viral infection | 11 |
focus group | 11 |
isolation centres | 11 |
described previously | 11 |
health emergency | 11 |
mechanical ventilation | 11 |
pcr assay | 11 |
world bank | 11 |
inflammatory response | 10 |
amino acids | 10 |
intracellular mature | 10 |
confirmed covid | 10 |
polymerase ii | 10 |
regulatory agencies | 10 |
outbreak years | 10 |
south america | 10 |
will also | 10 |
host proteins | 10 |
previous study | 10 |
innate immune | 10 |
specific health | 10 |
lung disease | 10 |
healthcare services | 10 |
influenza virus | 10 |
findings suggest | 10 |
fever viruses | 10 |
point mutations | 10 |
disease surveillance | 10 |
screening among | 10 |
economic factors | 10 |
care needs | 10 |
care systems | 10 |
asian meeting | 10 |
likelihood ratio | 10 |
critical care | 10 |
may provide | 10 |
evd survivor | 10 |
least two | 10 |
median age | 10 |
binding site | 10 |
past year | 10 |
virus rna | 10 |
evd positive | 10 |
health survey | 10 |
chart review | 10 |
children aged | 10 |
american population | 10 |
future research | 10 |
random assignment | 10 |
child health | 10 |
phylogenetic tree | 10 |
food security | 10 |
municipal solid | 10 |
higher level | 10 |
population density | 10 |
clinical care | 10 |
raw materials | 10 |
obesity compared | 10 |
peripheral blood | 10 |
nile virus | 10 |
controlled trial | 10 |
future development | 10 |
viral membranes | 10 |
different populations | 10 |
sexual abuse | 10 |
new immigrants | 10 |
smoking cessation | 10 |
gel electrophoresis | 10 |
several african | 10 |
human health | 10 |
cell deformability | 10 |
existing health | 10 |
cultural values | 10 |
inflammatory cytokine | 10 |
bootstrap replications | 10 |
study will | 10 |
eared fox | 10 |
molecular characterization | 10 |
wildlife trade | 10 |
random sample | 10 |
crack users | 10 |
higher levels | 10 |
among children | 10 |
genotype ii | 10 |
chronic kidney | 10 |
clinical presentation | 10 |
african context | 10 |
newly synthesized | 10 |
coding region | 10 |
domestic dogs | 10 |
private sector | 10 |
cell entry | 10 |
may contribute | 10 |
supplementary table | 10 |
cell culture | 10 |
systemic inflammation | 10 |
hiv infection | 10 |
isolates ard | 9 |
traditional values | 9 |
waste treatment | 9 |
tested positive | 9 |
current covid | 9 |
whereas cd | 9 |
sexual health | 9 |
better understand | 9 |
early detection | 9 |
odds ratios | 9 |
two years | 9 |
npc domain | 9 |
evolutionary processes | 9 |
reported comorbidities | 9 |
arf proteins | 9 |
health officials | 9 |
health problem | 9 |
urban populations | 9 |
low levels | 9 |
oxidative stress | 9 |
african union | 9 |
complete genome | 9 |
related deaths | 9 |
international collaboration | 9 |
web server | 9 |
reproductive health | 9 |
immune receptor | 9 |
carnivore species | 9 |
human consumption | 9 |
educational materials | 9 |
isolates characterized | 9 |
key ethical | 9 |
census data | 9 |
barkedji sen | 9 |
international human | 9 |
also observed | 9 |
secondary screening | 9 |
bango sen | 9 |
rights education | 9 |
cell disease | 9 |
authors declare | 9 |
first report | 9 |
class i | 9 |
real time | 9 |
nonstructural protein | 9 |
greater risk | 9 |
case management | 9 |
public assistance | 9 |
respiratory disease | 9 |
visual detection | 9 |
adhesion molecule | 9 |
drinking water | 9 |
eastern europe | 9 |
mediated isothermal | 9 |
critical illness | 9 |
nd bodies | 9 |
housekeeping genes | 9 |
missing data | 9 |
paper will | 9 |
marburg virus | 9 |
malaria infection | 9 |
age group | 9 |
times higher | 9 |
haemorrhagic fever | 9 |
higher rate | 9 |
sequencing data | 9 |
study also | 9 |
filovirus entry | 9 |
among black | 9 |
even though | 9 |
racial groups | 9 |
drug abuse | 9 |
diversifying selection | 9 |
age groups | 9 |
lfd assay | 9 |
membrane vesicles | 9 |
antigenic sites | 9 |
rapid spread | 9 |
protein kinase | 9 |
drug development | 9 |
different interventions | 9 |
may lead | 9 |
east asians | 9 |
isolate ard | 9 |
municipal wm | 9 |
mortality among | 9 |
comorbidity index | 9 |
health education | 9 |
statistical significance | 9 |
disease transmission | 9 |
th activity | 9 |
natural resources | 9 |
respiratory failure | 9 |
studies conducted | 9 |
screening rates | 9 |
substitution model | 9 |
edward jenner | 9 |
may help | 9 |
ard barkedji | 9 |
genome sequencing | 9 |
black population | 9 |
ebola vaccine | 9 |
lactic acidosis | 9 |
ns protein | 9 |
african court | 9 |
ard dakar | 9 |
agarose gel | 9 |
determine whether | 9 |
mental illness | 9 |
virus proteins | 9 |
viral hemorrhagic | 9 |
retrospective cohort | 9 |
immunity genes | 9 |
criminal justice | 9 |
arm studies | 9 |
blood test | 9 |
positive samples | 9 |
domestic dog | 9 |
also reported | 8 |
mean age | 8 |
ill patients | 8 |
obstructive lung | 8 |
tegument proteins | 8 |
urgent need | 8 |
fatality rates | 8 |
many countries | 8 |
latin america | 8 |
national park | 8 |
high blood | 8 |
one hand | 8 |
data entry | 8 |
ard diawara | 8 |
lumbar puncture | 8 |
whole blood | 8 |
first time | 8 |
available data | 8 |
treatment center | 8 |
one year | 8 |
institutional affiliations | 8 |
viral genomes | 8 |
syndromic surveillance | 8 |
fluid resuscitation | 8 |
sexual intercourse | 8 |
across populations | 8 |
comparative analysis | 8 |
zoonotic potential | 8 |
nucleotide sequence | 8 |
published maps | 8 |
nature remains | 8 |
genbank database | 8 |
seq data | 8 |
administrative data | 8 |
severe anaemia | 8 |
women living | 8 |
race ethnicity | 8 |
patient navigation | 8 |
attack rate | 8 |
mental disorders | 8 |
th century | 8 |
living cells | 8 |
genomic region | 8 |
pregnant evd | 8 |
working group | 8 |
patients hospitalized | 8 |
sexual experiences | 8 |
study may | 8 |
confocal microscopy | 8 |
digital connectedness | 8 |
advisory committee | 8 |
acute malaria | 8 |
odds ratio | 8 |
brain barrier | 8 |
paguma larvata | 8 |
care facilities | 8 |
canine parvovirus | 8 |
springer nature | 8 |
early stages | 8 |
health response | 8 |
red cells | 8 |
infected erythrocytes | 8 |
severe cases | 8 |
obstetric complications | 8 |
red cell | 8 |
site detection | 8 |
previously identified | 8 |
three major | 8 |
among caribbean | 8 |
pandemic preparedness | 8 |
andmouth disease | 8 |
resource allocation | 8 |
obstetric patient | 8 |
asian american | 8 |
medical research | 8 |
may play | 8 |
socioeconomic factors | 8 |
prothrombotic state | 8 |
research process | 8 |
cytoplasmic face | 8 |
environmental conditions | 8 |
cerebrospinal fluid | 8 |
test results | 8 |
past months | 8 |
communicable diseases | 8 |
genetic drift | 8 |
nonstructural proteins | 8 |
subcellular localization | 8 |
access health | 8 |
western medicines | 8 |
infected animals | 8 |
asf outbreaks | 8 |
different types | 8 |
acid extraction | 8 |
maximum likelihood | 8 |
population size | 8 |
breast milk | 8 |
second stage | 8 |
publicly available | 8 |
situation report | 8 |
infected individuals | 8 |
inclusion bodies | 8 |
also found | 8 |
healthcare systems | 8 |
medical waste | 8 |
virus isolates | 8 |
results show | 8 |
may result | 8 |
latinx patients | 8 |
bat npc | 8 |
method implemented | 8 |
critically ill | 8 |
genomic sequences | 8 |
positive results | 8 |
high rates | 8 |
health behaviors | 8 |
traditional burial | 8 |
diawara sen | 8 |
congestive heart | 8 |
demographic characteristics | 8 |
two groups | 8 |
remains neutral | 8 |
length variation | 8 |
previously available | 8 |
virus intracellular | 8 |
commonly used | 8 |
population structure | 8 |
mean cai | 8 |
seven ssa | 8 |
entry receptor | 8 |
data analysis | 8 |
nitric oxide | 8 |
note springer | 8 |
virus gene | 8 |
community based | 8 |
cell death | 8 |
african civet | 8 |
may explain | 8 |
core protein | 8 |
reading frames | 8 |
gene products | 8 |
endothelial cells | 8 |
per month | 8 |
case studies | 8 |
host species | 8 |
southern africa | 8 |
confidence interval | 8 |
blood cell | 8 |
poorly understood | 8 |
clan members | 8 |
positive patients | 8 |
adverse outcomes | 8 |
human housekeeping | 8 |
jurisdictional claims | 8 |
individual level | 8 |
high proportion | 8 |
npc gene | 8 |
asfv genotype | 8 |
policy makers | 8 |
analysis showed | 8 |
social groups | 8 |
adenovirus infection | 8 |
linkage disequilibrium | 8 |
dna viruses | 8 |
research institute | 8 |
rapid detection | 8 |
scarce resources | 8 |
physical health | 8 |
blood cells | 8 |
recombination regions | 8 |
human herpesvirus | 8 |
african child | 8 |
criteria decision | 8 |
evolutionary pressure | 8 |
regression analysis | 8 |
african lions | 8 |
poliovirus replication | 8 |
laboratory testing | 8 |
economic status | 8 |
human genes | 8 |
manufacturing facility | 8 |
relatively low | 8 |
community services | 8 |
physician visits | 7 |
limited resources | 7 |
fluorescent protein | 7 |
intervention group | 7 |
suspected cases | 7 |
significantly lower | 7 |
health impact | 7 |
young adult | 7 |
limited access | 7 |
national health | 7 |
lower odds | 7 |
abuse treatment | 7 |
became available | 7 |
taken together | 7 |
african instruments | 7 |
united kingdom | 7 |
vikor method | 7 |
three different | 7 |
takes place | 7 |
related health | 7 |
east asia | 7 |
primer set | 7 |
significant effect | 7 |
egyptian rousettes | 7 |
pcr products | 7 |
diagnostic test | 7 |
rousettus aegyptiacus | 7 |
genome replication | 7 |
fluorescence microscopy | 7 |
rapid diagnostic | 7 |
acid mutations | 7 |
clinical staff | 7 |
health inequalities | 7 |
worm infections | 7 |
detection platform | 7 |
street health | 7 |
vsv pseudotypes | 7 |
study participants | 7 |
minority immigrants | 7 |
variable region | 7 |
systemic lupus | 7 |
many patients | 7 |
see table | 7 |
first case | 7 |
obstetric population | 7 |
analysis using | 7 |
patients requiring | 7 |
recent studies | 7 |
vulnerable populations | 7 |
zip codes | 7 |
downtown toronto | 7 |
patients admitted | 7 |
preliminary findings | 7 |
associated encephalopathy | 7 |
states parties | 7 |
may facilitate | 7 |
control strategies | 7 |
capsid assembly | 7 |
multiplex detection | 7 |
educational level | 7 |
analyzed using | 7 |
service provision | 7 |
past years | 7 |
perinuclear areas | 7 |
public policies | 7 |
virus transmission | 7 |
term immunity | 7 |
mutation rates | 7 |
human infection | 7 |
various factors | 7 |
nine networks | 7 |
future studies | 7 |
rural african | 7 |
cvd risk | 7 |
outpatient care | 7 |
detailed information | 7 |
capsid layer | 7 |
recent years | 7 |
constructed using | 7 |
human house | 7 |
influenza preparedness | 7 |
using complete | 7 |
hepatitis virus | 7 |
primary outcome | 7 |
increase colorectal | 7 |
green zone | 7 |
current health | 7 |
health facilities | 7 |
disease among | 7 |
cell surface | 7 |
inflammatory diseases | 7 |
major role | 7 |
along microtubules | 7 |
young children | 7 |
primer sets | 7 |
hiv disease | 7 |
take part | 7 |
rna synthesis | 7 |
personal communication | 7 |
educational values | 7 |
distancing measures | 7 |
incubation period | 7 |
organisms reported | 7 |
south asia | 7 |
genetic heterogeneity | 7 |
central role | 7 |
cardiovascular diseases | 7 |
community development | 7 |
must also | 7 |
social status | 7 |
global pandemic | 7 |
will describe | 7 |
sterile syringes | 7 |
level care | 7 |
accession numbers | 7 |
randomized trial | 7 |
better understanding | 7 |
east asian | 7 |
several studies | 7 |
three countries | 7 |
management system | 7 |
will require | 7 |
social service | 7 |
wild animals | 7 |
four states | 7 |
risk communication | 7 |
family physicians | 7 |
wild carnivore | 7 |
across different | 7 |
crocuta crocuta | 7 |
angeles county | 7 |
africa ebola | 7 |
cycle assessment | 7 |
health risks | 7 |
viral assembly | 7 |
membraned vesicles | 7 |
intracellular movement | 7 |
virus protein | 7 |
social workers | 7 |
repeat allele | 7 |
asfv genome | 7 |
reading frame | 7 |
brucei gambiense | 7 |
recombinant viruses | 7 |
current study | 7 |
emerging infectious | 7 |
income countries | 7 |
nucleotide sequences | 7 |
health disparity | 7 |
total number | 7 |
many cases | 7 |
african evd | 7 |
african meeting | 7 |
environmental health | 7 |
intermediate filaments | 7 |
hand washing | 7 |
viral envelope | 7 |
based participatory | 7 |
starting point | 7 |
respiratory distress | 7 |
rna genome | 7 |
rna websuite | 7 |
blood sample | 7 |
membrane compartments | 7 |
research questions | 7 |
community partners | 7 |
large numbers | 7 |
particular attention | 7 |
target genes | 7 |
genetic variations | 7 |
fecal samples | 7 |
helvum npc | 7 |
data will | 7 |
ace inhibitor | 7 |
potential impact | 7 |
hypervariable regions | 7 |
studies involving | 7 |
clinical development | 7 |
zika virus | 7 |
poor health | 7 |
critical role | 7 |
coagulation status | 7 |
golgi transport | 7 |
three times | 7 |
conservative amino | 7 |
viral load | 7 |
cellular respiration | 7 |
gambiense hat | 7 |
sample sizes | 7 |
treatment centres | 7 |
community leaders | 7 |
keeping genes | 7 |
one third | 7 |
elixhauser comorbidity | 7 |
supplementary material | 7 |
study aimed | 7 |
viral inclusions | 7 |
emerging diseases | 7 |
immunodeficiency virus | 7 |
membrane association | 7 |
well known | 7 |
also identified | 7 |
adenovirus type | 7 |
two main | 7 |
living conditions | 7 |
attrition reported | 7 |
medical conditions | 7 |
replication occurs | 7 |
six months | 7 |
reported cases | 7 |
evolutionary history | 7 |
smoking status | 6 |
partial rdrp | 6 |
life expectancy | 6 |
lupus erythematosus | 6 |
intracellular virus | 6 |
mouse hepatitis | 6 |
diverse population | 6 |
clan territory | 6 |
serious health | 6 |
many asian | 6 |
conserved motif | 6 |
pubmed abstract | 6 |
histocompatibility complex | 6 |
participatory research | 6 |
natural history | 6 |
infection prevention | 6 |
intermediate compartment | 6 |
serengeti spotted | 6 |
infection status | 6 |
pulmonary disease | 6 |
several factors | 6 |
large urban | 6 |
study shows | 6 |
treatment technologies | 6 |
new urban | 6 |
copyright holder | 6 |
tumour necrosis | 6 |
many years | 6 |
target gene | 6 |
medical attention | 6 |
sw treatment | 6 |
table i | 6 |
immunogenomics studies | 6 |
fossil fuels | 6 |
one gene | 6 |
clinical data | 6 |
family viverridae | 6 |
mg ml | 6 |
angiotensin system | 6 |
east african | 6 |
travel restrictions | 6 |
health doi | 6 |
bagv adaptation | 6 |
virus infections | 6 |
dendritic cells | 6 |
broad range | 6 |
publisher full | 6 |
epidemic setting | 6 |
median household | 6 |
income communities | 6 |
health policies | 6 |
phase ii | 6 |
gene duplication | 6 |
world organization | 6 |
systematic reviews | 6 |
much higher | 6 |
community mobilization | 6 |
poliovirus proteins | 6 |
intravenous fluid | 6 |
international license | 6 |
urban centers | 6 |
aids outcomes | 6 |
regulatory protein | 6 |
underlying health | 6 |
laboratory confirmed | 6 |
first step | 6 |
virulence factor | 6 |
collected data | 6 |
diagnostic tests | 6 |
vitro studies | 6 |
level data | 6 |
case series | 6 |
child charter | 6 |
virus plaques | 6 |
safe sex | 6 |
available scientific | 6 |
evidence suggests | 6 |
gene insertions | 6 |
seven countries | 6 |
care advisors | 6 |
supplementary data | 6 |
large scale | 6 |
epidemic preparedness | 6 |
analysis included | 6 |
room temperature | 6 |
electron microscopic | 6 |
least three | 6 |
subcellular distribution | 6 |
health threats | 6 |
test kits | 6 |
marketing authorization | 6 |
competing interests | 6 |
infected patients | 6 |
intestinal parasitic | 6 |
genotype ix | 6 |
small sample | 6 |
time series | 6 |
pet ownership | 6 |
findings indicate | 6 |
studies included | 6 |
horseradish peroxidase | 6 |
issues related | 6 |
neurosurgical education | 6 |
knowledge scores | 6 |
supportive care | 6 |
may represent | 6 |
needle exchange | 6 |
health practice | 6 |
existing comorbidities | 6 |
org phil | 6 |
vulnerable groups | 6 |
sensitivity analysis | 6 |
consensus sequence | 6 |
existing traits | 6 |
virus nonstructural | 6 |
cellular proteins | 6 |
cellular protein | 6 |
will allow | 6 |
increased levels | 6 |
severe falciparum | 6 |
cellular origin | 6 |
vector control | 6 |
case report | 6 |
land use | 6 |
functional analysis | 6 |
immediate early | 6 |
north carolina | 6 |
african ancestry | 6 |
evd infection | 6 |
last years | 6 |
receptor gene | 6 |
time period | 6 |
zoonotic pathogens | 6 |
protein encoded | 6 |
african sample | 6 |
health infrastructure | 6 |
genetic analysis | 6 |
stroke prevention | 6 |
human services | 6 |
illicit drug | 6 |
greater covid | 6 |
may vary | 6 |
dense viroplasm | 6 |
child shall | 6 |
information criterion | 6 |
highest prevalence | 6 |
european court | 6 |
major parent | 6 |
significant difference | 6 |
central africa | 6 |
dna extraction | 6 |
aa residues | 6 |
african unity | 6 |
research methodology | 6 |
justice system | 6 |
vivax malaria | 6 |
issues surrounding | 6 |
among men | 6 |
poor prognosis | 6 |
creative commons | 6 |
countries will | 6 |
cytoplasmic factories | 6 |
social work | 6 |
isolates circulating | 6 |
gene tree | 6 |
parasite sequestration | 6 |
virus evolution | 6 |
swine blood | 6 |
molecular basis | 6 |
care facility | 6 |
green fluorescent | 6 |
will help | 6 |
negri bodies | 6 |
presenting symptoms | 6 |
sudv gp | 6 |
controlled trials | 6 |
appropriate treatment | 6 |
replication slippage | 6 |
key areas | 6 |
surveillance data | 6 |
viruses may | 6 |
best practices | 6 |
different levels | 6 |
genetic ancestry | 6 |
emerging pathogens | 6 |
dependent rna | 6 |
study designs | 6 |
health indicators | 6 |
factors influencing | 6 |
genetically distinct | 6 |
antibody anti | 6 |
multiple imputation | 6 |
urban dwellers | 6 |
virus spread | 6 |
key role | 6 |
public support | 6 |
data set | 6 |
percent change | 6 |
information regarding | 6 |
next generation | 6 |
american cancer | 6 |
abstract publisher | 6 |
provide information | 6 |
intermediate filament | 6 |
also seen | 6 |
antibody conjugated | 6 |
virus ns | 6 |
american residents | 6 |
take place | 6 |
policy development | 6 |
widely used | 6 |
er op | 6 |
quality care | 6 |
healthcare providers | 6 |
rights treaties | 6 |
genetic information | 6 |
rapid diagnosis | 6 |
patient care | 6 |
free environments | 6 |
health concerns | 6 |
ebola experience | 6 |
previous research | 6 |
federal government | 6 |
will continue | 6 |
mhc class | 6 |
dsdna viruses | 6 |
physical distancing | 6 |
protein synthesis | 6 |
mammalian cells | 6 |
protein icp | 6 |
voluntary sector | 6 |
experimental designs | 6 |
case counts | 6 |
vivax infection | 6 |
dn ds | 6 |
emphasis added | 6 |
rnaz method | 6 |
per year | 6 |
public engagement | 6 |
asfv infected | 6 |
acid motifs | 6 |
known spotted | 6 |
new infections | 6 |
quantitative data | 6 |
essential medicines | 6 |
glycosylation sites | 6 |
ethical principles | 6 |
term care | 6 |
genomic regions | 6 |
health effects | 6 |
likely due | 6 |
medical practitioners | 6 |
op visits | 6 |
urban area | 6 |
among older | 6 |
mature virus | 6 |
sexually abused | 6 |
genomic dna | 6 |
health centres | 6 |
vienna rna | 6 |
inadequate access | 6 |
demographic information | 6 |
requiring intensive | 6 |
selected sites | 6 |
blood tests | 6 |
transferrin receptor | 6 |
metropolitan areas | 6 |
viral entry | 6 |
control programs | 6 |
interventions may | 6 |
allelic variants | 6 |
good governance | 6 |
transcription factor | 6 |
low education | 6 |
infant formula | 6 |
death rate | 6 |
first stage | 6 |
integrin avb | 6 |
significant associations | 6 |
studies reported | 6 |
slum residents | 6 |
studies using | 6 |
papanicolau tests | 6 |
biological factors | 6 |
remains unclear | 6 |
based care | 6 |
participants also | 6 |
disabled children | 6 |
supplementary file | 6 |
social security | 6 |
population genetics | 6 |
study sample | 6 |
atrial fibrillation | 6 |
east respiratory | 6 |
informative sites | 6 |
culturally appropriate | 6 |
four southern | 6 |
statistical analyses | 6 |
among low | 6 |
dna virus | 6 |
national survey | 6 |
virus infected | 6 |
health programs | 6 |
female participants | 6 |
results showed | 6 |
state parties | 6 |
international concern | 6 |
human evolution | 6 |
health data | 6 |
test line | 6 |
also used | 6 |
gene set | 6 |
virus genome | 6 |
american female | 6 |
endothelial cell | 6 |
infection induces | 6 |
conceptual framework | 6 |
cell adhesion | 6 |
organ failure | 6 |
older adults | 6 |
tissue samples | 6 |
human personality | 6 |
fit kit | 6 |
long time | 6 |
average distance | 6 |
family medicine | 6 |
geographical distribution | 5 |
large dsdna | 5 |
parent virus | 5 |
western africa | 5 |
sample loading | 5 |
recent immigrants | 5 |
nuclear bodies | 5 |
religious groups | 5 |
potential role | 5 |
community participation | 5 |
adverse drug | 5 |
animal studies | 5 |
severe infection | 5 |
may differ | 5 |
equally important | 5 |
positively selected | 5 |
bat genomes | 5 |
warfarin therapy | 5 |
mature virions | 5 |
outbreak response | 5 |
hubei province | 5 |
process analysis | 5 |
densely populated | 5 |
asfv particles | 5 |
mainly due | 5 |
apparently healthy | 5 |
celiac disease | 5 |
health centers | 5 |
clinical practice | 5 |
pseudotypes bearing | 5 |
pseudorabies virus | 5 |
orthoreovirus factories | 5 |
providing health | 5 |
social media | 5 |
dr congo | 5 |
cytoplasmic structures | 5 |
toxoplasma gondii | 5 |
interim guidance | 5 |
ipc measures | 5 |
available evidence | 5 |
essential data | 5 |
maternal health | 5 |
new vaccines | 5 |
vast majority | 5 |
infectious ww | 5 |
disease caused | 5 |
chronic disease | 5 |
health organisation | 5 |
mosquito pools | 5 |
term monitoring | 5 |
diverse group | 5 |
leukemia protein | 5 |
important components | 5 |
microtubule organization | 5 |
mass transit | 5 |
occupancy rate | 5 |
medrxiv preprint | 5 |
high quality | 5 |
high population | 5 |
low sep | 5 |
currently available | 5 |
psychological distress | 5 |
virus african | 5 |
serengeti np | 5 |
version posted | 5 |
scale bar | 5 |
screening tests | 5 |
healthy city | 5 |
care provider | 5 |
every individual | 5 |
early proteins | 5 |
strong selective | 5 |
british columbia | 5 |
oral rehydration | 5 |
cancer society | 5 |
early career | 5 |
phylogenetically informative | 5 |
human cerebral | 5 |
complete polyprotein | 5 |
soft ticks | 5 |
major histocompatibility | 5 |
ivf environment | 5 |
related mortality | 5 |
religious leaders | 5 |
er markers | 5 |
poliovirus infection | 5 |
analytic hierarchy | 5 |
amniotic fluid | 5 |
will focus | 5 |
wild species | 5 |
ethnic communities | 5 |
late gene | 5 |
underdeveloped countries | 5 |
sampling dates | 5 |
aging chinese | 5 |
septic shock | 5 |
involving human | 5 |
protein vp | 5 |
health practitioners | 5 |
particularly among | 5 |
age categories | 5 |
reverse transcription | 5 |
infect cells | 5 |
dna binding | 5 |
ecological model | 5 |
gamma distribution | 5 |
urban environment | 5 |
care delivery | 5 |
host cells | 5 |
genbank accession | 5 |
community transmission | 5 |
global public | 5 |
health impacts | 5 |
strong evidence | 5 |
education system | 5 |
manufacturing process | 5 |
expected size | 5 |
marv gp | 5 |
african nations | 5 |
early diagnosis | 5 |
may predispose | 5 |
host immunity | 5 |
results will | 5 |
study examines | 5 |
give rise | 5 |
recombination detection | 5 |
community settings | 5 |
case definitions | 5 |
million liters | 5 |
evd outbreak | 5 |
poliovirus protein | 5 |
observed among | 5 |
divein web | 5 |
individuals living | 5 |
hoc red | 5 |
treatment programs | 5 |
year old | 5 |
control group | 5 |
care utilization | 5 |
emergency preparedness | 5 |
like receptors | 5 |
street children | 5 |
genome segments | 5 |
health related | 5 |
year period | 5 |
clinical samples | 5 |
sars cov | 5 |
study arms | 5 |
stage hat | 5 |
single cell | 5 |
hand sanitizers | 5 |
underserved communities | 5 |
th august | 5 |
results indicate | 5 |
discrete gamma | 5 |
sequences obtained | 5 |
data sources | 5 |
gene sequences | 5 |
grabbing nonintegrin | 5 |
experimental studies | 5 |
crystalline arrays | 5 |
stage renal | 5 |
widely accepted | 5 |
pig industry | 5 |
infect dis | 5 |
type lectins | 5 |
coat proteins | 5 |
obstetric care | 5 |
poor environmental | 5 |
demographic data | 5 |
mediterranean meeting | 5 |
risk assessment | 5 |
american college | 5 |
late times | 5 |
sep indicators | 5 |
pairwise comparison | 5 |
drug administration | 5 |
er proteins | 5 |
community involvement | 5 |
social exclusion | 5 |
will discuss | 5 |
allowed us | 5 |
conserved amino | 5 |
small number | 5 |
cultural rights | 5 |
obstructive pulmonary | 5 |
commercial kits | 5 |
nucleotide diversity | 5 |
extensive review | 5 |
virus isolated | 5 |
membrane proteins | 5 |
last year | 5 |
health access | 5 |
intervention studies | 5 |
parties involved | 5 |
basic health | 5 |
data gathered | 5 |
mutation rate | 5 |
text free | 5 |
colonial powers | 5 |
sep measures | 5 |
significantly different | 5 |
four different | 5 |
sexually transmitted | 5 |
proteins involved | 5 |
patients treated | 5 |
occult blood | 5 |
home based | 5 |
health inequities | 5 |
total energy | 5 |
genome sequence | 5 |
care worker | 5 |
kunjin virus | 5 |
also noted | 5 |
screening area | 5 |
icp foci | 5 |
urban agriculture | 5 |
community outreach | 5 |
municipal sw | 5 |
pandemic vaccines | 5 |
genetic distances | 5 |
ethnic minorities | 5 |
reference source | 5 |
health consequences | 5 |
health threat | 5 |
cellular response | 5 |
government health | 5 |
surveillance system | 5 |
kda band | 5 |
networks support | 5 |
qualitative study | 5 |
also requires | 5 |
clinically relevant | 5 |
whole genome | 5 |
posted june | 5 |
calorific value | 5 |
procedural ethics | 5 |
panthera leo | 5 |
group differences | 5 |
like receptor | 5 |
malarial parasites | 5 |
ethical approval | 5 |
next outbreak | 5 |
genetic adaptation | 5 |
public transportation | 5 |
baseline using | 5 |
evaluation criteria | 5 |
existing characteristics | 5 |
sought help | 5 |
protein also | 5 |
travel time | 5 |
genetic characterization | 5 |
gene content | 5 |
renal failure | 5 |
services use | 5 |
inferred using | 5 |
virus envelope | 5 |
granted medrxiv | 5 |
deaths worldwide | 5 |
rapid response | 5 |
epidemiological data | 5 |
genomic differences | 5 |
medical practitioner | 5 |
low attrition | 5 |
community level | 5 |
million people | 5 |
overall health | 5 |
eared foxes | 5 |
silver spring | 5 |
month period | 5 |
population differences | 5 |
molecular biology | 5 |
highly contagious | 5 |
susceptible individuals | 5 |
important lessons | 5 |
capillary array | 5 |
mass general | 5 |
special needs | 5 |
type inclusion | 5 |
stranded dna | 5 |
nutritional status | 5 |
eight genera | 5 |
chip framework | 5 |
central african | 5 |
insurance coverage | 5 |
lamp primers | 5 |
structured interviews | 5 |
chronic obstructive | 5 |
electronic supplementary | 5 |
raw material | 5 |
ebola response | 5 |
significant increase | 5 |
americans may | 5 |
control arm | 5 |
nucleotide polymorphisms | 5 |
also contain | 5 |
high viral | 5 |
coronary heart | 5 |
single nucleotide | 5 |
detailed data | 5 |
multiple hosts | 5 |
nm diameter | 5 |
different strains | 5 |
prenatal care | 5 |
highly variable | 5 |
human subjects | 5 |
million years | 5 |
dna samples | 5 |
will address | 5 |
among youth | 5 |
i will | 5 |
census tract | 5 |
mechanisms underlying | 5 |
water supply | 5 |
economically disadvantaged | 5 |
african commission | 5 |
prognostic significance | 5 |
women age | 5 |
general brigham | 5 |
genetic differences | 5 |
total population | 5 |
hospital care | 5 |
study using | 5 |
peer review | 5 |
expanded access | 5 |
copi coat | 5 |
yellow fever | 5 |
serial interval | 5 |
five years | 5 |
outreach worker | 5 |
government agencies | 5 |
infectious municipal | 5 |
fragile health | 5 |
gtr i | 5 |
renal disease | 5 |
high rate | 5 |
grounded theory | 5 |
reaction time | 5 |
detection methods | 5 |
virus structural | 5 |
detection method | 5 |
basic services | 5 |
obstetric patients | 5 |
qualitative data | 5 |
pbs containing | 5 |
virus production | 5 |
maternal mortality | 5 |
immature virions | 5 |
th position | 5 |
unpublished essential | 5 |
ultrastructural studies | 5 |
health providers | 5 |
african viruses | 5 |
sequence diversity | 5 |
tobacco mosaic | 5 |
golgi complex | 5 |
training programs | 5 |
pools collected | 5 |
telephone survey | 5 |
first place | 5 |
egfp fusion | 5 |
populations within | 5 |
also significantly | 5 |
nuclear domain | 5 |
secondary structure | 5 |
specific features | 5 |
challenges facing | 5 |
improve health | 5 |
among countries | 5 |
mock samples | 5 |
viral components | 5 |
sex workers | 5 |
without recombination | 5 |
single amino | 5 |
agreement indicates | 5 |
may require | 5 |
north america | 5 |
cultural perspectives | 5 |
intrinsic worth | 5 |
information systems | 5 |
mean distance | 5 |
medical records | 5 |
enveloped viruses | 5 |
among non | 5 |
treatment facilities | 5 |
direct contact | 5 |
total sample | 5 |
acid level | 5 |
igg antibody | 5 |
national institute | 5 |
direct lamp | 5 |
oxygen supply | 5 |
data quality | 5 |
protein secretion | 5 |
hierarchy process | 5 |
health emergencies | 5 |
methods used | 5 |
different groups | 5 |
npc binding | 5 |
hiv positive | 5 |
will share | 5 |
possible future | 5 |
hela cells | 5 |
severe illness | 5 |
disparities among | 5 |
human immunodeficiency | 5 |
secondary structures | 5 |
factors including | 5 |
molecular evolution | 5 |
wild birds | 5 |
based health | 5 |
reactive protein | 5 |
body fluids | 5 |
polymerase activity | 5 |
author funder | 5 |
fatality ratio | 5 |
intercellular adhesion | 5 |
uv irradiation | 5 |
secondary cases | 5 |
benefit analysis | 5 |
mathematical models | 5 |
comprehensive assessment | 5 |
poor outcomes | 5 |
care access | 5 |
virus strains | 5 |
pilot project | 5 |
data management | 5 |
premature mortality | 5 |
crucial role | 5 |
trend towards | 5 |
dumbbell structures | 5 |
mental status | 5 |
government officials | 5 |
western blotting | 5 |
individually known | 5 |
african descent | 5 |
posterior probability | 5 |
observational study | 5 |
clinical judgment | 5 |
bootstrap support | 5 |
highly divergent | 5 |
envelope protein | 5 |
oral anticoagulants | 5 |
linked glycosylation | 5 |
distress syndrome | 5 |
bovine serum | 5 |
human right | 5 |
production chain | 5 |
retinomax autorefractor | 5 |
mobile phone | 5 |
us population | 5 |
friendship among | 5 |
using data | 5 |
case line | 5 |
workshop will | 5 |
late viral | 5 |
contributed unpublished | 5 |
various african | 5 |
technical reports | 5 |
may occur | 5 |
free full | 5 |
diversity observed | 5 |
health promoters | 5 |
ikoma lyssavirus | 5 |
treatment centre | 5 |
cytopathic effect | 5 |
conserved sequence | 5 |
feeding practices | 5 |
research team | 5 |
nuclear matrix | 5 |
coronavirus pandemic | 5 |
nervous system | 5 |
better health | 5 |
assess whether | 5 |
promyelocytic leukemia | 5 |
provide evidence | 5 |
immunogenomics research | 5 |
large genetic | 5 |
personal experiences | 5 |
modified behaviors | 5 |
bedside care | 5 |
affected countries | 5 |
four meetings | 5 |
socioeconomic position | 5 |
informal settlements | 5 |
clinical settings | 5 |
pregnant patient | 5 |
sequences analyzed | 5 |
spotted hyaena | 5 |
infected pneumonia | 5 |
trypanosomiasis research | 5 |
local level | 5 |
urban women | 5 |
electron microscope | 5 |
hs education | 5 |
late stage | 5 |
virus glycoprotein | 5 |
traditional knowledge | 5 |
infection leads | 5 |
disease risk | 5 |
western countries | 5 |
del ecuador | 5 |
cytoplasmic assembly | 5 |
surface expression | 5 |
risks associated | 5 |
analysed using | 5 |
mortality due | 5 |
significant differences | 5 |
japanese encephalitis | 5 |
genetic material | 5 |
times postinfection | 5 |
tropical diseases | 5 |
new approaches | 5 |
genomes ranging | 5 |
support services | 4 |
chronic diseases | 4 |
surveillance systems | 4 |
nine neural | 4 |
significant impact | 4 |
average age | 4 |
national level | 4 |
disproportionate burden | 4 |
organisms listed | 4 |
nuclear structures | 4 |
based projects | 4 |
disease patients | 4 |
meets case | 4 |
may influence | 4 |
may need | 4 |
life technologies | 4 |
effective interventions | 4 |
increasing number | 4 |
potential score | 4 |
glycosylated sites | 4 |
model used | 4 |
effective treatment | 4 |
disproportionately affects | 4 |
lymph nodes | 4 |
required intubation | 4 |
among health | 4 |
captive viverrids | 4 |
infant mortality | 4 |
site model | 4 |
cellular function | 4 |
isolation facility | 4 |
herd immunity | 4 |
long history | 4 |
bearing ebov | 4 |
type infection | 4 |
highest proportion | 4 |
endemic regions | 4 |
already affected | 4 |
infection across | 4 |
family level | 4 |
transmission may | 4 |
best alternative | 4 |
screening recommendations | 4 |
many factors | 4 |
study outcomes | 4 |
approach used | 4 |
extraordinarily complex | 4 |
african scientists | 4 |
unique perspective | 4 |
zip code | 4 |
rpa assay | 4 |
filovirus host | 4 |
high level | 4 |
social environment | 4 |
international covenant | 4 |
independent risk | 4 |
least affected | 4 |
conditions may | 4 |
paradoxurus hermaphroditus | 4 |
block secretion | 4 |
protein interacts | 4 |
medical education | 4 |
native dutch | 4 |
human resources | 4 |
drug resistance | 4 |
antiretroviral therapy | 4 |
baseline data | 4 |
using eq | 4 |
pig farms | 4 |
recent registrants | 4 |
modelling study | 4 |
human person | 4 |
bodily integrity | 4 |
stage gambiense | 4 |
directly observed | 4 |
different organizations | 4 |
poverty line | 4 |
specific icam | 4 |
viral membrane | 4 |
icu level | 4 |
preventative health | 4 |
waste generation | 4 |
kidney patients | 4 |
coronavirus outbreak | 4 |
family caliciviridae | 4 |
participants discussed | 4 |
heath care | 4 |
remain unclear | 4 |
neural networks | 4 |
complete non | 4 |
mouse igg | 4 |
marital status | 4 |
clinical course | 4 |
number variation | 4 |
tailored educational | 4 |
genetic factors | 4 |
vaccine candidates | 4 |
multicriteria decision | 4 |
virus morphogenesis | 4 |
severity score | 4 |
recommended pcr | 4 |
also indicated | 4 |
polyprotein pp | 4 |
protein aggregates | 4 |
hispanic whites | 4 |
childhood sexual | 4 |
health canada | 4 |
challenges faced | 4 |
cell periphery | 4 |
herpesvirus infection | 4 |
disease pathogenesis | 4 |
positive evd | 4 |
adaptation index | 4 |
wide association | 4 |
observed across | 4 |
using antibodies | 4 |
pocket guide | 4 |
minority patients | 4 |
open access | 4 |
empowerment right | 4 |
falciparum infection | 4 |
pairwise comparisons | 4 |
geographical regions | 4 |
care settings | 4 |
human body | 4 |
next steps | 4 |
glucose intolerance | 4 |
mycobacterium tuberculosis | 4 |
strains circulating | 4 |
mild cases | 4 |
sample survey | 4 |
recognition receptors | 4 |
may limit | 4 |
manual chart | 4 |
flow assay | 4 |
relatively short | 4 |
informant interviews | 4 |
healthy child | 4 |
african residents | 4 |
laboratory tests | 4 |
enteric calicivirus | 4 |
different countries | 4 |
populations studied | 4 |
infectious wm | 4 |
completed high | 4 |
necessarily represent | 4 |
vsvs bearing | 4 |
adult patients | 4 |
different social | 4 |
porcine enteric | 4 |
among others | 4 |
modern human | 4 |
neighborhood poverty | 4 |
pcr amplification | 4 |
meeting participants | 4 |
life areas | 4 |
en ecuador | 4 |
health risk | 4 |
laboratory results | 4 |
ww management | 4 |
longitudinal study | 4 |
review board | 4 |
important consequences | 4 |
transmission models | 4 |
chinese msm | 4 |
local partners | 4 |
wildlife farms | 4 |
blood glucose | 4 |
recently developed | 4 |
egfp coding | 4 |
treatment services | 4 |
coronavirus pneumonia | 4 |
different age | 4 |
selective constraint | 4 |
known cases | 4 |
realtime pcr | 4 |
behavioral interventions | 4 |
hcv care | 4 |
african leaders | 4 |
genetta genetta | 4 |
golgi membranes | 4 |
food insecure | 4 |
genetic basis | 4 |
study aims | 4 |
indels observed | 4 |
membrane structures | 4 |
nuclear envelope | 4 |
structural coding | 4 |
ebov entry | 4 |
lassa fever | 4 |
reported weight | 4 |
challenges related | 4 |
samples collected | 4 |
body weight | 4 |
theoretical framework | 4 |
social citizenship | 4 |
cellular susceptibility | 4 |
european populations | 4 |
less developed | 4 |
outer capsid | 4 |
use data | 4 |
nurse practitioner | 4 |
urban neighborhoods | 4 |
manhattan i | 4 |
antigenic diversity | 4 |
patients required | 4 |
ul protein | 4 |
medical practice | 4 |
literature review | 4 |
stage clinical | 4 |
loci associated | 4 |
reaction system | 4 |
ebola hemorrhagic | 4 |
beth hayhoe | 4 |
energy imbalance | 4 |
archaic humans | 4 |
generation time | 4 |
major ethnic | 4 |
molecular techniques | 4 |
communications procedure | 4 |
arms races | 4 |
health agencies | 4 |
evolutionary genetics | 4 |
virally encoded | 4 |
enveloped virions | 4 |
functional constraint | 4 |
characteristics associated | 4 |
young adulthood | 4 |
control interventions | 4 |
basic human | 4 |
encephalopathic syndrome | 4 |
receptor genes | 4 |
angiotensin converting | 4 |
national lockdown | 4 |
depressive symptoms | 4 |
age years | 4 |
quantitative analysis | 4 |
civettictis civetta | 4 |
southeast asia | 4 |
inhibitory factor | 4 |
care provision | 4 |
financial support | 4 |
participants felt | 4 |
testing capacity | 4 |
flu pandemic | 4 |
ethnic background | 4 |
increased access | 4 |
interfering rnas | 4 |
community gardens | 4 |
punctate structures | 4 |
nkv flaviviruses | 4 |
poor healthcare | 4 |
statistically insignificant | 4 |
may involve | 4 |
resource settings | 4 |
asymptomatic infection | 4 |
us department | 4 |
microtubule network | 4 |
data need | 4 |
mortality associated | 4 |
data may | 4 |
significant predictors | 4 |
food system | 4 |
online version | 4 |
mammography screening | 4 |
neglected tropical | 4 |
household level | 4 |
affects multiple | 4 |
among male | 4 |
virus entry | 4 |
negative control | 4 |
large study | 4 |
disadvantaged populations | 4 |
contact rates | 4 |
clinical breast | 4 |
plan nacional | 4 |
every min | 4 |
genetic data | 4 |
bowel disease | 4 |
assessed using | 4 |
easily accessible | 4 |
screening adherence | 4 |
cell nucleus | 4 |
amplification combined | 4 |
highly transmissible | 4 |
receptor binding | 4 |
subcellular location | 4 |
population level | 4 |
children living | 4 |
coding genes | 4 |
relative risk | 4 |
gas production | 4 |
suspected asf | 4 |
native americans | 4 |
screening interventions | 4 |
stem cells | 4 |
possibly indicate | 4 |
human encephalitis | 4 |
default parameters | 4 |
first year | 4 |
increase stool | 4 |
large variety | 4 |
african hunting | 4 |
bayesian phylogenetic | 4 |
strains analyzed | 4 |
ethics approval | 4 |
underlying medical | 4 |
syringe exchange | 4 |
specific flaviviruses | 4 |
environmental factors | 4 |
school system | 4 |
multiple studies | 4 |
us census | 4 |
one hundred | 4 |
energy contribution | 4 |
ethical guidelines | 4 |
severe ebola | 4 |
antiviral response | 4 |
tnf promoter | 4 |
different dates | 4 |
first months | 4 |
early mrnas | 4 |
aids epidemic | 4 |
large dna | 4 |
treatment units | 4 |
applied biosystems | 4 |
past month | 4 |
mobility group | 4 |
high temperature | 4 |
viral polymerase | 4 |
linked immunosorbent | 4 |
higher prevalence | 4 |
also increase | 4 |
increase crc | 4 |
specific monoclonal | 4 |
acid change | 4 |
symptomatic patients | 4 |
encephalitis virus | 4 |
territorial integrity | 4 |
conducted using | 4 |
additionally adjusted | 4 |
spatial accessibility | 4 |
mcdm techniques | 4 |
immune functions | 4 |
acid sequences | 4 |
gfp signal | 4 |
human immunity | 4 |
neighborhood levels | 4 |
golgi network | 4 |
different regions | 4 |
target sequence | 4 |
close proximity | 4 |
risk behaviours | 4 |
intracellular enveloped | 4 |
car isolate | 4 |
recombination hotspot | 4 |
predominately composed | 4 |
brome mosaic | 4 |
rate categories | 4 |
using two | 4 |
close contact | 4 |
asfv factory | 4 |
racial differences | 4 |
holding units | 4 |
tissue culture | 4 |
first isolation | 4 |
integrated approach | 4 |
coronavirus infection | 4 |
test whether | 4 |
activity reports | 4 |
inflammatory responses | 4 |
racial discrimination | 4 |
hospitalized latinx | 4 |
hospitalization rates | 4 |
genomic analysis | 4 |
diagnostic capacity | 4 |
virus epidemic | 4 |
regulatory pathways | 4 |
immigrant population | 4 |
income urban | 4 |
method based | 4 |
reproduction number | 4 |
reported pre | 4 |
evd patients | 4 |
ultimate goal | 4 |
exposure data | 4 |
neighborhood scales | 4 |
second step | 4 |
molecular diagnosis | 4 |
contributing factor | 4 |
major cause | 4 |
fecal occult | 4 |
aids diagnosis | 4 |
interventions implemented | 4 |
plastic waste | 4 |
viral genes | 4 |
postpartum hemorrhage | 4 |
perinuclear sites | 4 |
peritoneal macrophages | 4 |
cigarette smoking | 4 |
information needs | 4 |
senegalese bagv | 4 |
shared care | 4 |
newcomer immigrants | 4 |
health statistics | 4 |
greatest risk | 4 |
galactosidase coding | 4 |
use disorders | 4 |
bagv genomes | 4 |
decision analysis | 4 |
assignment low | 4 |
research center | 4 |
contact rate | 4 |
thermodynamically stable | 4 |
asfv assembly | 4 |
also include | 4 |
african pteropodids | 4 |
cognitive difficulties | 4 |
positions highlighted | 4 |
diagnostic tools | 4 |
pathogen pressures | 4 |
community resources | 4 |
genome synthesis | 4 |
inflammatory bowel | 4 |
local parks | 4 |
large indels | 4 |
viral isolates | 4 |
equitable access | 4 |
factors may | 4 |
research methods | 4 |
community food | 4 |
related illness | 4 |
relevant data | 4 |
community organizations | 4 |
young neurosurgeons | 4 |
evolutionarily conserved | 4 |
infection dynamics | 4 |
governmental organizations | 4 |
fostering respect | 4 |
crispr cas | 4 |
highest rates | 4 |
negative results | 4 |
decision makers | 4 |
direct fluorescence | 4 |
analysis revealed | 4 |
pharmaceutical companies | 4 |
multivariate analyses | 4 |
synthesized viral | 4 |
approximately million | 4 |
protein trafficking | 4 |
binding properties | 4 |
municipal health | 4 |
healthcare access | 4 |
induced membranes | 4 |
native american | 4 |
south asian | 4 |
geographic region | 4 |
warfarin knowledge | 4 |
paying particular | 4 |
community engagement | 4 |
time lapse | 4 |
might contribute | 4 |
key challenges | 4 |
approach towards | 4 |
previous outbreaks | 4 |
fever virion | 4 |
neutrality tests | 4 |
research program | 4 |
helicobacter pylori | 4 |
population sizes | 4 |
genetic studies | 4 |
phase trials | 4 |
higher among | 4 |
scientific publications | 4 |
ideal solution | 4 |
comorbid conditions | 4 |
service needs | 4 |
early stage | 4 |
challenges identified | 4 |
response efforts | 4 |
new species | 4 |
contribute much | 4 |
protein sequences | 4 |
central variable | 4 |
deaths recorded | 4 |
sex groups | 4 |
averaged output | 4 |
human adaptation | 4 |
collaborative process | 4 |
depth interviews | 4 |
virus replicase | 4 |
grade inflammation | 4 |
support values | 4 |
also known | 4 |
social networks | 4 |
countries may | 4 |
special reference | 4 |
patient will | 4 |
diversity among | 4 |
prevention programs | 4 |
completely different | 4 |
neglected diseases | 4 |
health record | 4 |
electronic health | 4 |
main goal | 4 |
kinase ii | 4 |
conserved loop | 4 |
growing concern | 4 |
study conducted | 4 |
hr post | 4 |
high resource | 4 |
animal fat | 4 |